Tilray Brands (TLRY) Change in Cash (2017 - 2026)
Tilray Brands (TLRY) posted Change in Cash of $2.8 million for Q1 2026, up 115.46% on a QoQ basis from -$18.1 million in Q4 2025, and down 72.68% year-over-year from $10.3 million in Q1 2025.
Tilray Brands (TLRY) Change in Cash (2017 - 2026) Analysis & Trends
Tilray Brands' Change in Cash history runs 10 years deep, the most recent figure standing at $2.8 million for Q1 2026.
- Quarterly Change in Cash fell 72.68% year-over-year to $2.8 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $49.5 million (down 7.74% YoY) and the FY2025 annual result came in at -$6.7 million, down 130.74% from the prior year.
- Change in Cash was $2.8 million for Q1 2026 at Tilray Brands, up from -$18.1 million in the prior quarter.
- Across five years, Change in Cash topped out at $136.7 million in Q2 2022 and bottomed at -$300.4 million in Q4 2022.
- A 5-year average of -$4.8 million and a median of $1.3 million in 2024 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2022 — Change in Cash slumped 574.9% — and 2025, when it surged 686.66%.
- Tilray Brands' Change in Cash stood at -$300.4 million in 2022, then jumped by 88.62% to -$34.2 million in 2023, then soared by 54.69% to -$15.5 million in 2024, then slipped by 17.03% to -$18.1 million in 2025, then soared by 115.46% to $2.8 million in 2026.
- Business Quant data shows TLRY's Change in Cash at $2.8 million in Q1 2026, -$18.1 million in Q4 2025, and $43.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 185.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -509.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -388.85 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -277.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 457.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -117.00 Mn |
| 10 | Tilray Brands | 465.02 Mn | 373.06 Mn | 54.95 Mn | 2.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 2.80 Mn |
| Nov 30, 2025 | -18.13 Mn |
| Aug 31, 2025 | 43.16 Mn |
| May 31, 2025 | 21.71 Mn |
| Feb 28, 2025 | 10.26 Mn |
| Nov 30, 2024 | -15.49 Mn |
| Aug 31, 2024 | -23.15 Mn |
| May 31, 2024 | 82.09 Mn |
| Feb 29, 2024 | 1.30 Mn |
| Nov 30, 2023 | -34.18 Mn |
| Aug 31, 2023 | -27.50 Mn |
| May 31, 2023 | 41.64 Mn |
| Feb 28, 2023 | -25.22 Mn |
| Nov 30, 2022 | -300.43 Mn |
| Aug 31, 2022 | 74.73 Mn |
| May 31, 2022 | 136.70 Mn |
| Feb 28, 2022 | -52.57 Mn |
| Nov 30, 2021 | -44.51 Mn |
| Aug 31, 2021 | -112.17 Mn |
| May 31, 2021 | 277.88 Mn |